ACH-5228 delivers near complete and sustained inhibition of the complement alternative pathway Twice-daily oral administration to move forward in Phase 2 trials Investigational New Drug (IND) ...
You can blame it on stage fright, but when the lights go up, the Nokia 5228 pales in comparison to rival budget phones. Despite its self-proclaimed star quality, it just doesn't have the X factor to ...
Yesterday, kind of secretly, Nokia announced the 5228. At first look you will hardly find difference between the newbie and its sibling, the Nokia 5230. But that's only because it is hidden deep under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results